20 Results for "

Factor XI

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "Factor XI" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-114164H
CAS No.: 9002-04-4
Synonyms: EC 3.4.21.5 (Lyophilized); Human Alpha Thrombin (Lyophilized)
Human α-Thrombin (EC 3.4.21.5; Human Alpha Thrombin) (Lyophilized) is a terminal serine protease in the coagulation cascade, as well as a potent physiological platelet agonist and fibrin-generating enzyme in vivo. Human α-Thrombin catalyzes the conversion of fibrinogen to fibrin for blood clot formation, and activates platelet aggregation by cleaving the protease-activated receptors PAR1 (major) (Kd = 1 nM) and PAR4 (minor) on the platelet surface to expose tethered ligands. Human α-Thrombin also amplifies coagulation via positive feedback by activating coagulation factors V, VIII, XI (FV/FVIII/FXI), and switches to activate protein C to exert anticoagulant effects after binding to thrombomodulin .
This product is in a freeze-dried form.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P991124
CAS No.: 3008610-21-4
Synonyms: REGN-7508

Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Cenvacibart is a monoclonal antibody with anticoagulant activity, targeting human coagulation factor XI (F11). Cenvacibart blocks the role of coagulation factor XI in the coagulation cascade, reducing thrombus formation. Cenvacibart is promising for research of thrombotic diseases .
loading...
    loading...
Cat. No.: HY-156613
CAS No.: 1803270-60-1
Purity:  97.16%
Synonyms: EP-7041
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Frunexian (EP-7041) is a small-molecule activated factor XI (FXIa) inhibitor. Frunexian has the characteristics of rapid onset and offset of action, a short half-life, dose-dependent prolongation of activated partial thromboplastin time, and an extremely low risk of bleeding. Frunexian exhibits good safety and tolerability and can be used in research related to thrombocytopenia, thromboembolism, thromboembolic diseases, and COVID-19 .
loading...
    loading...
Cat. No.: HY-175735
CAS No.: 2563884-39-7
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Factor XI-IN-2 is a Factor XI activation inhibitor with an IC50 of 20 nM. Factor XI-IN-2 does not directly inhibit the enzymatic activity of FXIa, but specifically binds to the FXI enzyme precursor and allosterically inhibits the process by which it is activated by FXIIa. Factor XI-IN-2 inhibits thrombosis in the rabbit arteriovenous (AV) shunt thrombosis model. Factor XI-IN-2 can be used for the study of antithrombus .
loading...
    loading...
Cat. No.: HY-143477
CAS No.: 2720619-72-5
Research Areas:  

Cardiovascular Disease

Factor XI-IN-1 is an activator inhibitor of coagulation factor XI (Factor XI) with an EC50 of 25.14 nM. Factor XI-IN-1 is applicable to research related to thrombosis, embolism, hypercoagulable states and fibrotic changes .
loading...
    loading...
Cat. No.: HY-107966A
CAS No.: 37270-89-6
Synonyms: Nadroparin calcium (MW 3600-5000)
Heparin (Nadroparin) calcium (MW 3600-5000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
Cat. No.: HY-151196
CAS No.: 2816108-08-2
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

FXIa-IN-10 (Compound 3f) is a potent activated factor XI (FXIa) inhibitor with an Ki of 0.17 nM. FXIa-IN-10 has good oral bioavailability .
loading...
    loading...
Fesomersen sodium
0 Images
DNA, d([2′-O-(2-methoxyethyl)]rA-sp-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-A-sp-T-sp-T-sp-G-sp-G-sp-T-sp-G-sp-m5C-sp-A-sp-m5C-sp-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rU-sp-[2′-O-(2-methoxyethyl)]m5rU-sp-[2′-O-(2-methoxyethyl)]m5rU), 5′-[26-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[6-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]hexyl]amino]-3-oxopropoxy]methyl]-8,12,19-trioxo-16-oxa-7,13,20-triazahexacos-1-yl hydrogen phosphate], sodium salt (1:20)
Cat. No.: HY-139788A
CAS No.: 2380288-85-5
Purity:  98.67%
Synonyms: ION-957943; BAY-2976217; IONIS-FXI-LRx sodium
Fesomersen (sodium) is an antisense oligonucleotide designed to inhibit the production of Factor XI.
loading...
    loading...
Cat. No.: HY-107966
CAS No.: 37270-89-6
Synonyms: Nadroparin calcium (MW 15000-19000)
Heparin calcium (MW 15000-19000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
Cat. No.: HY-177669
CAS No.: 3061406-99-0
Synonyms: RBD4059
Vortosiran (RBD4059) is a siRNA that inhibits the synthesis of coagulation factor XI (FXI). Vortosiran shows potent inhibitory activity against mouse FXI transcripts with an IC50 of 69 pM; it exerts similar effects on common FXI transcripts from humans and monkeys, with an IC50 of 59 pM. Vortosiran exhibits antithrombotic activity without impairing hemostatic function. Vortosiran can be used in research related to intravascular thrombosis .
loading...
    loading...
Cat. No.: HY-177669A
Synonyms: RBD4059 sodium
Vortosiran (RBD4059) sodium is a siRNA that inhibits the synthesis of coagulation factor XI (FXI). Vortosiran sodium shows potent inhibitory activity against mouse FXI transcripts with an IC50 of 69 pM; it exerts similar effects on common FXI transcripts from humans and monkeys, with an IC50 of 59 pM. Vortosiran sodium exhibits antithrombotic activity without impairing hemostatic function. Vortosiran sodium can be used in research related to intravascular thrombosis .
loading...
    loading...
Fesomersen
0 Images
DNA, d([2′-O-(2-methoxyethyl)]rA-sp-[2′-O-(2-methoxyethyl)]m5rC-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rC-A-sp-T-sp-T-sp-G-sp-G-sp-T-sp-G-sp-m5C-sp-A-sp-m5C-sp-[2′-O-(2-methoxyethyl)]rA-[2′-O-(2-methoxyethyl)]rG-[2′-O-(2-methoxyethyl)]m5rU-sp-[2′-O-(2-methoxyethyl)]m5rU-sp-[2′-O-(2-methoxyethyl)]m5rU), 5′-[26-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[6-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]hexyl]amino]-3-oxopropoxy]methyl]-8,12,19-trioxo-16-oxa-7,13,20-triazahexacos-1-yl hydrogen phosphate]
Cat. No.: HY-139788
CAS No.: 2380135-03-3
Synonyms: ION-957943 free acid; BAY-3563450; IONIS-FXI-LRx
Fesomersen is an antisense oligonucleotide designed to inhibit the production of Factor XI.
loading...
    loading...
Cat. No.: HY-W091734
CAS No.: 158686-46-5
Methyl 4-iodo-L-phenylalaninate hydrochloride is a Phenylalaninate derivative. Methyl 4-iodo-L-phenylalaninate hydrochloride can be used for the preparation of factor XI modulators used in the research of thrombotic and thromboembolic. Methyl 4-iodo-L-phenylalaninate hydrochloride can also be used for the synthesis of compounds for the research of amyloid-related diseases, such as Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-P73046
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: F11; Plasma Thromboplastin Antecedent; Coagulation Factor XI; Coagualtion Factor XI; FXI; PTA
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P700978
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: F11; Plasma Thromboplastin Antecedent; Coagulation Factor XI; Coagualtion Factor XI; FXI; PTA
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703948
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: F11; Plasma Thromboplastin Antecedent; Coagulation Factor XI; Coagualtion Factor XI; FXI; PTA
Species:  
Rabbit
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-183409
CAS No.: 1941243-22-6
Synonyms: ONO-5450598
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

ONO-7684 (ONO-5450598) is an orally active coagulation factor XIa (FXIa) inhibitor with a Ki value of 2 nM against human FXIa. ONO-7684 inhibits human FXIa in a competitive and reversible manner, reduces factor XI coagulation activity, prolongs activated partial thromboplastin time in a dose-dependent manner, and exerts no significant effects on PT/INR and the activity of related serine proteases. ONO-7684 exerts antithrombotic effects in vivo without prolonging bleeding time. ONO-7684 can be used in studies related to thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-156613A
CAS No.: 2416857-24-2
Synonyms: EP-7041 hydrochloride
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Frunexian (EP-7041) hydrochloride is a small-molecule activated factor XI (FXIa) inhibitor. Frunexian hydrochloride has the characteristics of rapid onset and offset of action, a short half-life, dose-dependent prolongation of activated partial thromboplastin time, and an extremely low risk of bleeding. Frunexian hydrochloride exhibits good safety and tolerability and can be used in research related to thrombocytopenia, thromboembolism, thromboembolic diseases, and COVID-19 .
loading...
    loading...
Cat. No.: HY-177669C
Synonyms: FAM labled RBD4059 sodium
FAM labled Vortosiran sodium (RBD4059) a FAM labled Vortosiran sodium. Vortosiran sodium is a siRNA that inhibits the synthesis of coagulation factor XI (FXI). Vortosiran sodium shows potent inhibitory activity against mouse FXI transcripts with an IC50 of 69 pM; it exerts similar effects on common FXI transcripts from humans and monkeys, with an IC50 of 59 pM. Vortosiran sodium exhibits antithrombotic activity without impairing hemostatic function. Vortosiran sodium can be used in research related to intravascular thrombosis .
loading...
    loading...
Cat. No.: HY-177669D
Synonyms: Cy3 labled RBD4059 sodium
Cy3 labled Vortosiran (RBD4059) sodium is a Cy3 labled Vortosiran sodium. Vortosiran (RBD4059) sodium is a siRNA that inhibits the synthesis of coagulation factor XI (FXI). Vortosiran sodium shows potent inhibitory activity against mouse FXI transcripts with an IC50 of 69 pM; it exerts similar effects on common FXI transcripts from humans and monkeys, with an IC50 of 59 pM. Vortosiran sodium exhibits antithrombotic activity without impairing hemostatic function. Vortosiran sodium can be used in research related to intravascular thrombosis .
loading...
    loading...
  • 1